Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68065-11-2

Post Buying Request

68065-11-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68065-11-2 Usage

General Description

4-(3-Bromo-propoxy)-phenol is a chemical compound with the chemical formula C9H11BrO2. It is a derivative of phenol, featuring a bromine atom and a propoxy (CH3CH2CH2O) group attached to the phenol ring. The compound is used primarily as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. It can also be used as a reagent in organic synthesis and as a building block in the preparation of other organic compounds. Although it is not widely studied for biological or toxicological effects, it is important to handle this compound with caution and use proper personal protective equipment due to its potential hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 68065-11-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,0,6 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 68065-11:
(7*6)+(6*8)+(5*0)+(4*6)+(3*5)+(2*1)+(1*1)=132
132 % 10 = 2
So 68065-11-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H11BrO2/c10-6-1-7-12-9-4-2-8(11)3-5-9/h2-5,11H,1,6-7H2

68065-11-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3-bromopropoxy)phenol

1.2 Other means of identification

Product number -
Other names Phenol,4-(3-bromopropoxy)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68065-11-2 SDS

68065-11-2Relevant articles and documents

Ionic-liquid supported rapid synthesis of an: N -glycan core pentasaccharide on a 10 g scale

Li, Wei,Gao, Yu,Li, Qing,Li, Zhong-Jun

supporting information, p. 4720 - 4727 (2018/07/06)

A new and efficient Ionic Liquid-Supported Oligosaccharide Synthesis (ILSOS) strategy for an N-linked core pentasaccharide on a 10 g scale is reported. This new ILSOS includes a new spacer for an IL support, a new tagging strategy, and fast, efficient and orthogonal removal of the ionic-liquid support, producing the N-linked core pentasaccharide with direct applicability potential in a short time, with high yield and on a large gram scale.

Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia

Bell-Horwath, Tiffany R.,Vadukoot, Anish K.,Thowfeik, Fathima Shazna,Li, Guorui,Wunderlich, Mark,Mulloy, James C.,Merino, Edward J.

supporting information, p. 2951 - 2954 (2013/06/27)

This study explores the possible use of reactive oxygen-activated DNA modifying agents against acute myeloid leukemia (AML). A key amine on the lead agent was investigated via cytotoxicity assays and was found necessary for potency. The two best compounds were screened via the NCI-60 cell panel. These two compounds had potency between 200 and 800 nM against many of the leukemia cancer cell types. Subsequent experiments explored activity against a transformed AML model that mimics the molecular signatures identified in primary AML patient samples. A lead compound had an IC50 of 760 nM against this AML cell line as well as a therapeutic index of 7.7 ± 3 between the transformed AML model cell line and non-cancerous human CD34+ blood stem/progenitor cells (UCB). The selectivity was much greater than the mainstays of AML treatment: doxorubicin and cytarabine. This manuscript demonstrates that this novel type of agent may be useful against AML.

LTA4H modulators and uses thereof

-

Page/Page column 28, (2008/12/07)

Leukotriene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68065-11-2